Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
复制标题
DOI:
10.1038/sj.onc.1201829
复制
发表时间:
1998-02-12
期刊:
影响因子:
8
通讯作者:
Leder, P
中科院分区:
文献类型:
--
作者:
Amundadottir, LT;Leder, P
We have assessed five signal transduction pathways to determine the role each might play in the malignant transformation of mammary epithelium initiated by neu, heregulin/NDF, TGF alpha, v-Ha-ras and c-myc in transgenic mice. The study involves a molecular and pharmacologic assessment of Erk/MAP kinase, Jnk/SAP kinase, PI 3-kinase, protein kinase C, and the Src-related kinases Lck and Fyn., Our results indicate that oncogenes capable of transforming mammary gland epithelium activate and require specific signal transduction pathways, For example, mammary tumors initiated by neu, v-Ha-ras as and c-myc have high levels of active Erk/MAP kinase and their anchorage independent growth is strongly inhibited by PD098059, an inhibitor of Mek/ MAP kinase kinase, By contrast, Erk/MAP I;kinase activity is weak in tumors initiated by TI;TFG alpha and heregulin/NDF and the corresponding cell lines are not growth inhibited by PD098059, Similarly, PI 3-kinase is strongly activated in neu, TGF alpha;! and heregulin/NDF initiated tumor cell lines, but not in c-myc or v-Ha-rns initiated tumor cell lines, The anchorage independent growth of all these tumor cell lines are, however, inhibited by the specific PI 3-kinase inhibitor LY294001. Further illustrating this oncogene-based specificity, PP1, a specific inhibitor of the Src-like kinases, Lck and Fyn, blocks anchorage-independent cell growth only in the TGF alpha;cl initiated mammary tumor cell line, Taken together with additional observations, we conclude that certain oncogenes reliably require the recruitment/activation of specific signal transduction pathways, Such specific relationships between the initiating oncogene and a required pathway may reflect a direct activating effect or the parallel activation of a pathway that is a necessary oncogenic collaborator for transformation in the mammary gland, The work points to a molecular basis for targeting therapy when an initiating oncogene can be implicated; for example, because of amplification, increased expression, genetic alteration, or heritable characteristics.